115689-97-9

Upstream product

• 84379-54-4 (R)-2-(benzyloxy)-2-[(R)-2,2-dimethyl-1,3-dioxolan-4-yl]ethanol 
• 124-63-0 methanesulfonyl chloride 
• 84379-53-3 dl-2-O-benzyl-3,4-O-isopropylideneerythritol 
• 84379-51-1 dl-2-O-benzylerythritol 
• 84379-53-3 dl-2-O-benzyl-3,4-O-isopropylidenethreitol 
• 38270-70-1 dimethyl meso-2,3-O-benzylidenetartrate 
• 100-52-7 benzaldehyde 
• 91326-83-9 (4S,5S)-dimethyl 2-phenyl-1,3-dioxolane-4,5-dicarboxylate 
• 84379-51-1 2-O-benzyl-L-threitol 

Downstream Products

• 115689-96-8 (2R,3S)-3-O-benzyl-4-iodo-1,2-O-isopropylidenebutane-1,2,3-triol 
• 115690-06-7 (2R,3R)-3-benzyloxy-6-(tert-butyldiphenylsiloxy)-1-triphenylmethoxyhexan-2-ol 
• 115690-08-9 Methanesulfonic acid (1R,2R)-2-benzyloxy-5-(tert-butyl-diphenyl-silanyloxy)-1-trityloxymethyl-pentyl ester 
• 119116-56-2 <(2S,3R)-3-benzyloxytetrahydropyran-2-yl>methanol 
• 115887-36-0 (4R)-4-(benzyloxy)-4-((4R)-2,2-dimethyl-1,3-dioxolan-4-yl)butan-1-ol 
• 126840-43-5 (2S,3R)-3-benzyloxy-2-methoxymethoxymethyltetrahydropyran 
• 115690-02-3 ethyl (4R,5R)-4-benzyloxy-5,6-isopropylidenedioxyhexanoate 
• 115690-00-1 ethyl (4R,5R)-4-benzyloxy-2-ethoxycarbonyl-5,6-isopropylidenedioxyhexanoate 
• 115690-05-6 (2R,3R)-3-benzyloxy-6-(tert-butyldiphenylsiloxy)hexane-1,2-diol 
• 115690-09-0 (2S,3R)-3-benzyloxy-2-triphenylmethoxymethyltetrahydropyran 
• 115690-04-5 (2R,3R)-3-benzyloxy-6-(tert-butyldiphenylsiloxy)-1,2-isopropylidenedioxyhexane 
• 115690-07-8 (2R,3R)-3-benzyloxy-6-hydroxy-1-triphenylmethoxy-2-hexyl methanesulfonate 
• 115689-96-8 dl-erythro-3-O-benzyl-4-iodo-1,2-O-isopropylidenebutane-1,2,3-triol 
• 126906-86-3 dl-trans-4-benzyloxy-6-hydroxy-5-hexanolide 

Relevant academic research and scientific papers

Production of optically active 2 - vinylcyclopropane - 1, 1 - dicarboxylic acid ester

Provided is a method for producing an optically active 1-amino-2-vinylcyclopropane-1-carboxylic acid ester and 2-vinylcyclopropane-1,1-dicarboxylic acid ester, which do not isomerize during a reaction, with an inexpensive and easily obtainable optically a

Cyclic ether derivatives and their use

Compounds of formula (I): STR1 (wherein: l is 2-4; A and B are oxygen or sulfur; one of R1 and R2 represents a long chain alkyl, alkylcarbamoyl or aliphatic acyl group and the other of R1 and R2 represents a group of formula (III) or (IIf): STR2 in which E represents a single bond, a bivalent heterocyclic group or a group of formula --CO--, --COO-- or --CONR6 --, where R6 is hydrogen or an imino-protecting group; m is 0-3; n is 0-10; q is 0 or 1; R4 is optionally protected hydroxy, mercapto group or carboxy; Q is an amino or nitrogen-containing heterocyclic group; Rf4 Rf5 and Rf6 are independently selected from the group consisting of hydrogen atoms and C1 -C6 alkyl groups, or Rf4 and Rf5 or Rf4, Rf5 and Rf6, together with the nitrogen atom to which they are attached, form a heterocyclic ring) are PAF antagonists which may be used to treat asthma, hypotension, inflammation and shock. They may be prepared by reacting the corresponding compound having a haloalkyl phosphate ester or alkylenephosphate ester group in place of the ammonioalkyl phosphate ester group with an appropriate amine.